MedTrace Logo

Effect of a Natural Health Product on Urinary Estrogen Metabolites

NCT01089049 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2012-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine if a supplemental formula can beneficially alter the ratio of urinary estrogen metabolites.

Conditions

Interventions

DIETARY_SUPPLEMENT

FemMED Breast Health Formula

Two capsules daily, with meals. FemMED Breast Health Formula containing lignans.

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    lead NETWORK

Principal Investigators

  • Maggie Laidlaw, P.hD · Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-04-30
Completion
2010-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01089049 on ClinicalTrials.gov